The CRADA establishes a collaborative framework on medical countermeasures that protect global populations and U.S. soldiers ...
Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...
Ability to avoid pretransplant chemotherapy could open up stem cell transplants for patients who might otherwise be too sick ...
The FDA PreCheck Pilot Program will focus on manufacturing readiness, regulatory predictability, and expedited facility ...
A regulatory protein in astrocytes may explain how certain memories persist over time for learning and cognitive function.
New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.
Fast, local cryopreservation is a consistent bottleneck for autologous cell therapy developers, even in major cell and gene therapy hubs.
USP’s Diane McCarthy on the emerging standards platform and opportunities for stakeholders to help shape standards evolution.
Novartis has agreed to acquire Myricx Bio, a London-based developer of next-generation antibody-drug conjugates (ADCs), for ...
To test this strategy, the team engineered protein immunogens that mimic key HIV envelope structures known to initiate bnAb ...
Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, in a deal that would expand the ...
As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results